» Articles » PMID: 35992099

Dimerization of GPCRs: Novel Insight into the Role of FLNA and SSAs Regulating SST and SST Homo- and Hetero-dimer Formation

Overview
Specialty Endocrinology
Date 2022 Aug 22
PMID 35992099
Authors
Affiliations
Soon will be listed here.
Abstract

The process of GPCR dimerization can have profound effects on GPCR activation, signaling, and intracellular trafficking. Somatostatin receptors (SSTs) are class A GPCRs abundantly expressed in pituitary tumors where they represent the main pharmacological targets of somatostatin analogs (SSAs), thanks to their antisecretory and antiproliferative actions. The cytoskeletal protein filamin A (FLNA) directly interacts with both somatostatin receptor type 2 (SST) and 5 (SST) and regulates their expression and signaling in pituitary tumoral cells. So far, the existence and physiological relevance of SSTs homo- and hetero-dimerization in the pituitary have not been explored. Moreover, whether octreotide or pasireotide may play modulatory effects and whether FLNA may participate to this level of receptor organization have remained elusive. Here, we used a proximity ligation assay (PLA)-based approach for the visualization and quantification of SST/SST dimerization in rat GH3 as well as in human melanoma cells either expressing (A7) or lacking (M2) FLNA. First, we observed the formation of endogenous SST homo-dimers in GH3, A7, and M2 cells. Using the PLA approach combined with epitope tagging, we detected homo-dimers of human SST in GH3, A7, and M2 cells transiently co-expressing HA- and SNAP-tagged SST. SST and SST can also form endogenous hetero-dimers in these cells. Interestingly, FLNA absence reduced the basal number of hetero-dimers (-36.8 ± 6.3% reduction of PLA events in M2, P < 0.05 . A7), and octreotide but not pasireotide promoted hetero-dimerization in both A7 and M2 (+20.0 ± 11.8% and +44.1 ± 16.3% increase of PLA events in A7 and M2, respectively, P < 0.05 . basal). Finally, immunofluorescence data showed that SST and SST recruitment at the plasma membrane and internalization are similarly induced by octreotide and pasireotide in GH3 and A7 cells. On the contrary, in M2 cells, octreotide failed to internalize both receptors whereas pasireotide promoted robust receptor internalization at shorter times than in A7 cells. In conclusion, we demonstrated that in GH3 cells SST and SST can form both homo- and hetero-dimers and that FLNA plays a role in the formation of SST/SST hetero-dimers. Moreover, we showed that FLNA regulates SST and SST intracellular trafficking induced by octreotide and pasireotide.

Citing Articles

A supramolecular FRET signal amplification nanoprobe for high contrast and synchronous imaging of cell surface receptor homodimers/heterodimers.

Wang Y, Yao F, Song L, Zhang M, Gong Z, Zhao Y Chem Sci. 2025; 16(11):4732-4740.

PMID: 39968283 PMC: 11831222. DOI: 10.1039/d4sc08004a.

References
1.
Pfeiffer M, Koch T, Schroder H, Laugsch M, Hollt V, Schulz S . Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. J Biol Chem. 2002; 277(22):19762-72. DOI: 10.1074/jbc.M110373200. View

2.
Rocheville M, Lange D, Kumar U, Sasi R, Patel R, Patel Y . Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J Biol Chem. 2000; 275(11):7862-9. DOI: 10.1074/jbc.275.11.7862. View

3.
Duran-Prado M, Malagon M, Gracia-Navarro F, Castano J . Dimerization of G protein-coupled receptors: new avenues for somatostatin receptor signalling, control and functioning. Mol Cell Endocrinol. 2008; 286(1-2):63-8. DOI: 10.1016/j.mce.2007.12.006. View

4.
Abdalla S, Lother H, Quitterer U . AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature. 2000; 407(6800):94-8. DOI: 10.1038/35024095. View

5.
Patel Y . Somatostatin and its receptor family. Front Neuroendocrinol. 1999; 20(3):157-98. DOI: 10.1006/frne.1999.0183. View